Research progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012618 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Yuchen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inspection and Quarantine, Shanghai Customs College, Shanghai, China. Hauptthemen laut MEDLINE: Arthropod Vectors, Salivary Proteins and Peptides, Vaccine Development, Vector Borne Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Startup Research Fund from the Shanghai Customs College.
Abstract (Originalsprache)
Hematophagous arthropods, including mosquitoes, ticks, and flies, are responsible for the transmission of several pathogens to vertebrates on whom they blood feed. The diseases caused by these pathogens, collectively known as vector-borne diseases (VBDs), threaten the health of humans and animals. In general, attempts to develop vaccines for pathogens transmitted by arthropods have met with moderate success, with few vaccine candidates currently developed. Nowadays, there are vaccine candidates under clinical trials, including different platforms, like mRNA, DNA, recombinant viral vector-based, virus-like particles (VLPs), inactivated-virus, live-attenuated virus, peptide and protein-based vaccines, all of them based on the presentation of pathogen antigens to the host immune system. A new approach to prevent VBDs has arose during the last decades, based on the design of vaccines that target vector-derived antigens. The salivary secretions of arthropods, in addition of causing allergic reactions and harbor pathogens, are also involved in the transmission and infection establishment in the host, altering its immune responses. In this review, we summarize the achievements in the arthropod salivary-based vaccine development for different vector-borne infectious diseases. This provides a rationale for creating vaccines against different types of arthropod salivary proteins, such as mosquitoes, ticks, and sand flies. Using salivary proteins of clinically important vectors might contribute to achieve protection against and control multiple arthropod-borne infection diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Inspection and Quarantine, Shanghai Customs College, Shanghai, China.
- Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
ORCID-Profile: Yuchen Wang
Förderung
- the Startup Research Fund from the Shanghai Customs College
Zitieren
APA
Wang, Y., Ling, L., Jiang, L., & Marin-Lopez, A. (2024). Research progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012618
Vancouver
Wang Y, Ling L, Jiang L, Marin-Lopez A. Research progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012618
BibTeX
@article{Wang2024,
author = {Wang, Yuchen and Ling, Lin and Jiang, Lijie and Marin-Lopez, Alejandro},
title = {Research progress toward arthropod salivary protein vaccine development for vector-borne infectious diseases},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012618}
}
EUVIMED